TheProfitWatch

ROIV - Roivant Sciences Ltd. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
20.38 -0.16 (-0.79%) -0.01 (-0.05%) -0.03 (-0.15%) 0.01 (0.05%) -0.11 (-0.54%) -0.04 (-0.2%) 0.0 (0.0%) 0.17 (0.85%)

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.33
Diluted EPS:
-0.33
Basic P/E:
-61.2727
Diluted P/E:
-61.2727
RSI(14) 1m:
57.41
VWAP:
20.23
RVol:

Events

Period Kind Movement Occurred At

Related News